Tongtong Wang

Tongtong Wang currently serves as the Global Head of Technical Development at Roche, where collaboration with global research and development organizations focuses on advancing the Roche portfolio through scalable manufacturing processes. Prior to this role, Tongtong Wang was the VP and Head of Pharma Technical Development at Genentech, building end-to-end technical development capabilities for the US biological portfolio. Tongtong Wang's extensive experience also includes positions at Eli Lilly and Company, where leadership spanned bioprocess R&D, clinical material supply, and regulatory submissions. Earlier roles at Corixa Corporation involved leading process development initiatives, and foundational research was conducted as a Postdoctoral Researcher at Cornell University. Tongtong Wang holds a PhD in Biology/Biochemistry from Syracuse University and Baylor College of Medicine, and a B.Sc in Molecular Biology from the University of Science and Technology of China.